NCT06456970View on ClinicalTrials.gov

Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes

Not yet recruitingOBSERVATIONAL

Enrollment

140

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2026

Conditions

Fatty Liver

Interventions

DEVICE

fibroscan

"Fibroscan examination with controlled attenuation parameterCAP (Echosens FibroScan ® Compact 530) for evaluation of steatosis and its degree (by CAP score) and fibrosis stage by liver stiffness measurement(LSM)"

All Listed Sponsors

lead

Assiut University

OTHER

NCT06456970 - Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes | Biotech Hunter | Biotech Hunter